Biological E received the go-ahead from The Drug Controller General of India to conduct phase 2 and 3 trials for its COVID vaccine called “Corbevax”. Children between 5-18 years of age will receive the jab during the clinical trials. Government has already placed an order of 30 crore vaccines with the Hyderabad based firm.
The COVID situation in India is steadily improving. In the past 24 hours, India saw 41,965 new cases and 33,964 recoveries. Ministry of Information and Broadcasting disclosed these stats on their twitter handle India fights Corona.
Meanwhile, the needle-less COVID vaccine called ZyCoV-D has received emergency use authorization. They can administer their vaccine on children in the age group of 12-18 years. The vaccine will be administered from October onwards. Also, the trials for Bharat Biotech’s Covaxin for children is underway. Results of the trials are expected in September.
(Image Credits: Wikipedia)